EMYSF Easymed Technologies Inc (CE)

EquityNet Research announced today that it has initiated research coverage on EasyMed Services, Inc. (OTCPK:EMYSF) (CNSX:EZM) (MSE:EY6.MU) with a 12-month target price of $4.12.

EquityNet initiated a BUY rating for EasyMed, a global healthcare information technology company marketing proprietary end-to-end smartphone patient care solutions, five years in development and with key certifications, including IBM's Health Integration Framework (HIF), HL7 and HIPAA.

EasyMed has five core applications; the focus of this report is on two: Easy SmartCare, the Company's two-way communication system for patients and provider organizations; and the International Medical Passport, an online personal health record and service finder that goes with travelers anywhere in the world they do. Both applications are completed and no further development is needed.

According to the report, the smartphone application market for mobile healthcare will reach $1.3 billion in 2012 – up from $718 million in 2011. Despite this substantial growth, the "mHealth" market is still in its infant stage – especially when compared to the $6 trillion of the overall global healthcare market. Several factors, especially smartphone penetration and national healthcare cost reduction programs, will continue, however, to drive mHealth market growth.

"We feel that the Company is certainly in the right place at the right time. It is obvious that demand is and will remain very strong for mobile health 'mHealth' applications well into the foreseeable future, and the market itself is huge. Valuations for most health IT stocks have remained relatively strong despite recent market turbulence," stated Mr. Randy Lewis, CFA, Founder and Senior Analyst with EquityNet who is covering the Company. "In addition, we feel the company's International Medical Passport is a particularly strong product, lending itself to a subscription model, which typically has an exponential effect on revenue when a product or service catches on."

EasyMed Services opened at $0.63 on the day the report was completed and is now $1.08. The company has a 1-year low of US$0.52 (CAD $0.46) and a 1-year high of $1.08 (CAD $1.35).

A full copy of the EasyMed Report is available at EquityNet Research's website: www.equitynet.net (http://www.equitynet.net/researchreports.aspx). 

About EquityNet Research

EquityNet Research, an independent equity research firm, was formed to provide the public with independent, objective research on under-followed companies. It does this by preparing detailed reports that highlight the key aspects of each company and its industry. EquityNet does not have extraneous relationships with its followed-companies nor has any present or future pecuniary benefit other than that disclosed for each company on its website. EquityNet was compensated $20,000 by the subject company for the preparation of the Easymed report. EquityNet is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any specific securities.

CONTACT: EquityNet Research
         Randy Lewis, CFA, MBA
         Senior Analyst
         rlewis@equitynet.net
         818.783.5006